tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Tommie Reerink, 3 are a SELL (100%).
Analyst Tommie Reerink, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 100% that have a potential upside of 22.37% achieved within 69 days. Previously, Tommie Reerink worked at RAYMOND JAMES.
Tommie Reerink’s has documented 5 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ATRA, Atara Biotherapeutics at 17-Jul-2024.
Analyst best performing recommendations are on ATRA (ATARA BIOTHERAPEUTICS).
The best stock recommendation documented was for ATRA (ATARA BIOTHERAPEUTICS) at 7/17/2024. The price target of $11 was fulfilled within 1 day with a profit of $1.05 (8.71%) receiving and performance score of 87.14.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 08-May-2026
$13
$2.49 (23.69%)
$6
2 months 6 days ago
(08-May-2026)
5/7 (71.43%)
$4.66 (55.88%)
542
Buy Since 18-Aug-2025
$18
$7.49 (71.27%)
$16
7 months 23 days ago
(21-Nov-2025)
4/6 (66.67%)
$4.32 (31.58%)
167
Hold Since 22-May-2024
1 years 5 months 16 days ago
(28-Jan-2025)
2/4 (50%)
$129.5 (20.06%)
149
Hold Since 02-Nov-2023
$5
$-5.51 (-52.43%)
$10
1 years 5 months 23 days ago
(21-Jan-2025)
3/5 (60%)
$-1.05 (-17.36%)
310
Buy Since 04-Jan-2021
$25
$14.49 (137.87%)
1 years 6 months 24 days ago
(20-Dec-2024)
0/2 (0%)
$13.6 (119.30%)
What Year was the first public recommendation made by Tommie Reerink?
